Literature DB >> 23348332

Prevalence and characteristics of HPV infection in oropharyngeal cancer.

Antonella De Stefani1, Paolo Boffano, Gianluca Averono, Angela Ramella, Francesco Pia, Guido Bongioannini.   

Abstract

BACKGROUND: The purpose of this prospective study was to analyze the human papillomavirus (HPV) infection status and its impact on the outcome in a consecutive series of patients affected by oropharyngeal cancer.
METHODS: The specimens of consecutive subjects surgically treated for oropharyngeal squamous cell carcinoma were obtained. Samples were collected by broom-type cell sampling devices and they underwent the Roche Linear Array HPV Genotyping Test to identify the presence of HPV types.
RESULTS: In all, 52 patients were enrolled. The presence of HPV was detected in 13 samples, with HPV type 16 as the most frequently encountered type. Statistically significant associations were found between HPV-positive patients and a higher tumor grading (P < 0.05), and between HPV-positive patients and a higher number of negative prognostic factors (P < 0.05).
CONCLUSIONS: A subset of oropharyngeal squamous cell carcinomas with a higher tumor grading is strongly linked to HPV16 infection.

Entities:  

Mesh:

Year:  2013        PMID: 23348332     DOI: 10.1097/SCS.0b013e31826cfffa

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals.

Authors:  Erin Martin; Juliet Dang; Davit Bzhalava; Joshua Stern; Zoe R Edelstein; Laura A Koutsky; Nancy B Kiviat; Qinghua Feng
Journal:  J Clin Virol       Date:  2013-11-01       Impact factor: 3.168

Review 2.  Towards the eradication of HPV infection through universal specific vaccination.

Authors:  Piergiorgio Crosignani; Antonella De Stefani; Gaetano Maria Fara; Andrea M Isidori; Andrea Lenzi; Carlo Antonio Liverani; Alberto Lombardi; Francesco Saverio Mennini; Giorgio Palu'; Sergio Pecorelli; Andrea P Peracino; Carlo Signorelli; Gian Vincenzo Zuccotti
Journal:  BMC Public Health       Date:  2013-07-11       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.